Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-28

FDA Approved: OXYMORPHONE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

The FDA approved a supplemental application for Oxymorphone hydrochloride from Amneal Pharmaceuticals of New York LLC (ANDA 079087).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxymorphone hydrochloride (Oxymorphone hydrochloride)

Snippet

SUPPL AP for OXYMORPHONE HYDROCHLORIDE (OXYMORPHONE HYDROCHLORIDE)